Global and United States Synthetic Blood Substitutes and Blood Product Market Report & Forecast 2022-2028

Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient's immediate blood supply needs and to extend his or her life.
Market Analysis and Insights: Global and United States Synthetic Blood Substitutes and Blood Product Market

This report focuses on global and United States Synthetic Blood Substitutes and Blood Product market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Synthetic Blood Substitutes and Blood Product market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Human Blood accounting for % of the Synthetic Blood Substitutes and Blood Product global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals and Clinics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Synthetic Blood Substitutes and Blood Product market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Synthetic Blood Substitutes and Blood Product Scope and Market Size

Synthetic Blood Substitutes and Blood Product market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Synthetic Blood Substitutes and Blood Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Synthetic Blood Substitutes and Blood Product market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Synthetic Blood Substitutes and Blood Product market is segmented into

Human Blood

Animal Blood

Microorganisms

Synthetic Polymers

Stem Cells

Others

Segment by Application, the Synthetic Blood Substitutes and Blood Product market is segmented into

Hospitals and Clinics

Blood Banks

Others

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Synthetic Blood Substitutes and Blood Product Market Share Analysis

Synthetic Blood Substitutes and Blood Product market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Synthetic Blood Substitutes and Blood Product business, the date to enter into the Synthetic Blood Substitutes and Blood Product market, Synthetic Blood Substitutes and Blood Product product introduction, recent developments, etc.

The major vendors covered:

Aurum Biosciences Ltd

Hemarina SA

KaloCyte Inc.

NuvOx Pharma LLC

Northfield Laboratories

Dentritech, Inc.

HemoBioTech, Inc.

Dextro-Sang Corp.

Baxter International

FluorO2 Therapeutics

Alpha Therapeutic Corp.

Hemoglobin Oxygen Therapeutics LLC

SpheriTech Ltd

Sangart, Inc.

BioPure